Diabetes Insights - Breakthroughs and Innovators

• The Future of Type 2 Diabetes - Where Are We Going?

  In this episode, Prof. Emma Ahlqvist (Lund University) and Prof. Matthias Blüher (University of Leipzig) join host Vivienne Parry to explore the future of type 2 diabetes. They unpack the shift from a one-size-fits-all approach to one that embraces stratified and personalised care. From using machine learning to define diabetes subtypes to applying AI tools for screening, they share how new approaches could enable earlier diagnosis, better treatment choices, and improved outcomes. With obesity increasingly recognised as a chronic disease and not merely a lifestyle issue, they also discuss the need for broader access to therapies - and how stigma continues to stand in the way of effective treatment. Join us for an inspiring glimpse into what diabetes care could look like by 2034. #DiabetesCare #Type2Diabetes #PersonalisedMedicine #AI

  --------  

  15:39
• When Sex is Ex - Sexual Problems in Diabetes

  In this episode of Diabetes Insights, we’re talking about a topic that doesn’t get nearly enough attention in diabetes care: Sexual Health. Studies show that people with diabetes are twice as likely to experience sexual dysfunction, yet many patients and healthcare professionals struggle to discuss it openly. Join host Vivienne Parry as she speaks with Dr. Aleksandra Uruska, a diabetologist from Poznań University of Medical Sciences, and Dr. Marieke Dewitte, a clinical psychologist and sexologist from Maastricht University. Together, they explore the biological, psychological, and social factors affecting sexual health in diabetes, the importance of breaking the stigma, and how healthcare providers can better support patients in addressing these challenges.

  --------  

  10:27
• Targeting Obesity to Treat Heart Failure - With Preserved Ejection Fraction (HFpEF)

  Could weight loss be the key to managing heart failure? In this episode of Diabetes Insights, we dive into the STEP-HFpEF trial, a groundbreaking study exploring the role of GLP-1 receptor agonists in heart failure with preserved ejection fraction (HFpEF). Host Vivienne Parry speaks with Prof. Melanie Davies (University of Leicester), Prof. Mark Petrie (University of Glasgow), and Prof. Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, USA) about the link between obesity, diabetes, and HFpEF, and how weight management could transform heart failure treatment. With trials already in motion to explore prevention, could we stop HFpEF before it starts? Join us for this insightful conversation on targeting obesity to treat heart failure.

  --------  

  9:39
• Avoiding Complications at Onset - The Future of Type 1 Diabetes Screening and Care

  In this episode of Diabetes Insights, we explore the power of screening in type 1 diabetes and the potential for early intervention. Host Vivienne Parry speaks with EASD President, Prof. Chantal Mathieu and Prof. Annette Ziegler about groundbreaking research into detecting type 1 diabetes in its earliest stages. With new disease-modifying therapies on the horizon, early screening is no longer just about preventing complications at diagnosis but it could delay the onset of diabetes and open doors to future treatments. We discuss how registries, European-wide collaboration, and real-world screening initiatives are shaping the future of early detection, patient monitoring, and clinical trials. Join us for this insightful conversation on how screening could transform type 1 diabetes care.

  --------  

  12:48
• Shaping Policy for Better Diabetes Care - European Diabetes Forum (EUDF)

  In this episode, we dive into the critical role of the European Diabetes Forum (EUDF) in shaping diabetes policy across Europe. Host Vivienne Parry speaks with Bart Torbeyns about why bringing together stakeholders - including patient associations, research institutions, healthcare professionals, and industry - is essential to influencing policy makers and improving access to diabetes care. We discuss the importance of securing diabetes on the EU agenda, tackling the rising costs of diabetes, and addressing misconceptions around obesity and new therapeutics. With European elections reshaping healthcare priorities, how can the diabetes community push for action? Join us for a compelling discussion on the future of diabetes policy, prevention, and care.

  --------  

  8:38

Meer Wetenschap podcasts

Trending Wetenschap -podcasts

Over Diabetes Insights - Breakthroughs and Innovators